首页|Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Gene and cell therapies for a variety of life-limiting illnesses are under investigation, and a small number of commercial products have successfully obtained regulatory approval. The cost of treatment is high, and clinical studies evaluating safety and efficacy are performed predominately in high-income countries. We reviewed the current status of gene and cell therapies in low- and middle-income countries and highlighted the need and current barriers to access. The state of product development in Brazil, South Africa, and India is discussed, including lessons learned from American Society of Gene and Cell Therapy (ASGCT)-sponsored virtual symposia in each of these countries.
NSTL
Elsevier
